Healthpeak Properties, Inc., trading as DOC on the NYSE, is a real estate investment trust (REIT) that focuses on owning and developing healthcare properties. The company operates in a competitive market, with peers like Ventas and Welltower. Healthpeak's portfolio includes medical offices, life science facilities, and senior housing, positioning it as a key player in the healthcare real estate sector.
On February 3, 2025, Healthpeak reported earnings per share (EPS) of $0.01, missing the estimated $0.05. Despite this, the company showed good FFO number for the quarter ending December 2024. The Diluted FFO per share for that quarter was $0.46, surpassing the consensus estimate of $0.45, as highlighted by Zacks.
Healthpeak's revenue for the quarter was approximately $698 million, slightly below the estimated $698.3 million. However, this figure marked a 26.1% increase compared to the same period last year. The revenue also exceeded the Zacks Consensus Estimate of $694 million, resulting in a positive surprise of 0.55%, showcasing the company's strong financial health.
The company's financial ratios provide further insight into its market valuation. Healthpeak has a price-to-earnings (P/E) ratio of 58.13, indicating that investors are willing to pay $58.13 for every dollar of earnings. Its price-to-sales ratio is 6.67, suggesting the market values the company at 6.67 times its sales. The enterprise value to sales ratio is 10.74, reflecting the company's total valuation relative to its sales.
Despite these positive indicators, Healthpeak faces some challenges. The current ratio of 0.63 suggests potential liquidity issues in covering short-term liabilities with current assets. Additionally, the debt-to-equity ratio of 1.04 indicates a moderate level of debt financing relative to equity. These factors could influence investor sentiment and the stock's future price performance.
Read More